CMXC
vs
S&P 500
CMXC
S&P 500
Over the past 12 months, CMXC has outperformed S&P 500, delivering a return of +17% compared to the S&P 500's +14% growth.
Stocks Performance
CMXC vs S&P 500
Performance Gap
CMXC vs S&P 500
Performance By Year
CMXC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cell MedX Corp
Glance View
Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. The company is headquartered in Carson City, Nevada. The company went IPO on 2013-03-11. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its proprietary eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The Company’s eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities (legs) due to strain from exercise or normal household- or work-related activities, as well as for general relaxation.